Ligand validation:4D0T

UD2: URIDINE-DIPHOSPHATE-N-ACETYLGALACTOSAMINE

UD2 is a Ligand Of Interest in 4D0T designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4D0T_UD2_A_1574	87%	27%	0.107	0.979	1.08	1.86	3	17	2	0	100%	1
4D0T_UD2_D_1571	80%	25%	0.116	0.965	1.11	1.91	4	18	5	0	100%	1
4D0T_UD2_E_1571	77%	23%	0.132	0.971	0.96	2.2	1	19	1	0	100%	1
4D0T_UD2_B_1573	75%	24%	0.128	0.961	1.06	2	3	21	2	0	100%	1
4D0T_UD2_F_1567	75%	30%	0.121	0.953	0.89	1.85	2	12	2	0	100%	1
6EGS_UD2_B_602	35%	41%	0.206	0.896	0.89	1.4	2	7	12	0	100%	1
1OQM_UD2_D_528	96%	22%	0.061	0.971	1.58	1.66	7	14	6	0	100%	1
6EJI_UD2_B_401	95%	8%	0.067	0.969	2.3	2.35	11	19	1	0	100%	1
8DQD_UD2_A_401	93%	32%	0.078	0.971	1.09	1.58	3	13	2	0	100%	1
8JJQ_UD2_A_401	92%	54%	0.08	0.969	0.63	1.15	-	7	4	0	100%	1
6WJA_UD2_A_402	90%	27%	0.088	0.972	1.25	1.67	3	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.